Teacher Retirement System Of Texas Uni Qure N.V. Transaction History

Teacher Retirement System Of Texas

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	BUY	$6.71 - $11.83 $7,743 - $13,651	1,154 Added 10.06%	12,625 $85,000
Q2 2023 Jul 19, 2023	SELL	$11.12 - $22.2 $16,768 - $33,477	-1,508 Reduced 11.62%	11,471 $131,000
Q1 2023 May 12, 2023	BUY	$18.7 - $23.07 $5,703 - $7,036	305 Added 2.41%	12,979 $261,000
Q4 2022 Feb 10, 2023	SELL	$18.12 - $27.32 $19,859 - $29,942	-1,096 Reduced 7.96%	12,674 $287,000
Q3 2022 Nov 03, 2022	BUY	$16.98 - $25.54 $233,814 - $351,685	13,770 New	13,770 $258,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Teacher Retirement System Of Texas with notifications on news.